This company seems to have been delisted
Reason: Acquired by Merck
Source: https://www.merck.com/news/merck-completes-acquisition-of-acceleron-pharma-inc/
Reason: Acquired by Merck
Source: https://www.merck.com/news/merck-completes-acquisition-of-acceleron-pharma-inc/
Acceleron Pharma
XLRN
£138.43
Share price
0.00%
Change (1 day)
14,714.87%
Change (1 year)
Categories
Revenue for Acceleron Pharma (XLRN)
Revenue in 2021 (TTM): £82.64 Million
According to Acceleron Pharma's latest financial reports the company's current revenue is £87.32 Million. In 2020 the company made a revenue of £71.65 Million an increase over the revenue in the year 2019 that were of £57.3 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Acceleron Pharma from 2012 to 2021
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2021 (TTM) | £82.64 M | 15.34% |
| 2020 | £71.65 M | 25.05% |
| 2019 | £57.3 M | 428.85% |
| 2018 | £10.83 M | 3.78% |
| 2017 | £10.44 M | -51.45% |
| 2016 | £21.5 M | 53.47% |
| 2015 | £14.01 M | 23.68% |
| 2014 | £11.33 M | -74.43% |
| 2013 | £44.31 M | 275.17% |
| 2012 | £11.81 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 | £25.88 B | 29,540.67% | 🇺🇸 USA |
 | £10.99 B | 12,494.45% | 🇺🇸 USA |
 | £68.78 B | 78,667.16% | 🇺🇸 USA |
 | £0.17 M | -99.80% | 🇺🇸 USA |
 | £40.49 M | -53.63% | 🇺🇸 USA |
 | £41.13 M | -52.89% | 🇺🇸 USA |
 | £49.27 B | 56,324.04% | 🇺🇸 USA |